Abstract
The Northern Ireland Biobank (NIB) was established in 2011 as a joint initiative between Queen’s University Belfast and Belfast Health and Social Care Trust to provide the infrastructure for the standardised collection and storage of high quality, well annotated human tissue samples, with matched bloods and bodily fluids to underpin cancer research in Northern Ireland and beyond. The NIB has been instrumental in supporting translational research locally, nationally and internationally with a number of key achievements to date. The vision of NIB is to develop an internationally recognised biobank network within Northern Ireland which collects, stores and distributes high quality, clinically annotated biospecimens for biomarker research to benefit cancer patients. Funding statement: NIB receives core funding from the Health and Social Care Research and Development Division of the Public Health Agency in Northern Ireland with charitable funding from Friends of the Cancer Centre. NIB previously received charitable funding from Cancer Research UK and Prostate Cancer UK.
Highlights
(1) Bioresource Overview Project description The Northern Ireland Biobank (NIB) is currently a disease specific biobank and was awarded full ethical approval in August 2011 for the collection of tumour and nontumour control tissues and associated biospecimens from patients with a suspected or confirmed diagnosis of cancer [1]
NIB’s status as a fully ethically approved tissue bank offers substantial benefits for researchers who apply to use tissue procured by NIB
NIB have a straightforward application system based on the UK’s Integrated Research Application System with efficient turnaround times, offering a significant advantage to researchers who are have traditionally faced lengthy delays when applying for individual project based approvals from local research ethics committees
Summary
The NIB has been instrumental in supporting translational research locally, nationally and internationally with a number of key achievements to date. The vision of NIB is to develop an internationally recognised biobank network within Northern Ireland which collects, stores and distributes high quality, clinically annotated biospecimens for biomarker research to benefit cancer patients. (1) Bioresource Overview Project description The Northern Ireland Biobank (NIB) is currently a disease specific biobank and was awarded full ethical approval in August 2011 for the collection of tumour and nontumour control tissues and associated biospecimens from patients with a suspected or confirmed diagnosis of cancer [1]. A rigorous regulatory framework which complies with research ethics and governance requirements for handling of human biospecimens for research This provides timely release of samples to researchers with scientifically approved projects.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
